JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M409492200 on November 9, 2004

J. Biol. Chem., Vol. 280, Issue 2, 1217-1223, January 14, 2005
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
280/2/1217    most recent
M409492200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Li, Y.
Right arrow Articles by Altman, A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y.
Right arrow Articles by Altman, A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Role for Protein Kinase C{theta} (PKC{theta}) in TCR/CD28-mediated Signaling through the Canonical but Not the Non-canonical Pathway for NF-{kappa}B Activation*

Yingqiu Li{ddagger}§, Caitlin E. Sedwick{ddagger}, Junru Hu{ddagger}, and Amnon Altman{ddagger}||

From the {ddagger}Division of Cell Biology, La Jolla Institute for Allergy and Immunology, San Diego, California 92121 and the §State Key Laboratory of Biocontrol, College of Life Sciences, Sun Yat-sen University, Guangzhou, 510275, China

NF-{kappa}B is a family of essential transcription factors involved in both embryonic development and inflammatory responses of the immune system. NF-{kappa}B can be activated by two pathways, i.e. the canonical (NF-{kappa}B1) pathway, which acts through the catalytic components of the I{kappa}B kinase complex and leads to I{kappa}B phosphorylation, degradation, and subsequent NF-{kappa}B nuclear translocation, or the non-canonical (NF-{kappa}B2) pathway, which involves NF-{kappa}B-induced kinase-dependent proteolytic processing of p100/p52 to yield translocation-competent p52-containing NF-{kappa}B complexes. We examined the relative roles of the NF-{kappa}B1 and NF-{kappa}B2 pathways in TCR/CD28 costimulation. We found that TCR/CD28 costimulation activates the canonical but not the non-canonical NF-{kappa}B pathway and that the serine/threonine kinase protein kinase C{theta} (PKC{theta}) is essential for TCR/CD28-mediated canonical NF-{kappa}B activation in T cells. Importantly, TCR/CD28 costimulation induces higher p52 protein levels in T cells, but this effect is secondary to enhanced de novo synthesis of p100, not to enhanced processing of extant p100; PKC{theta} deficiency impairs signal-dependent p52 accumulation because of defects in p100 production. Finally, we found that TCR/CD28 costimulation induces I{kappa}B{alpha}, I{kappa}B{beta}, and I{kappa}B{epsilon} degradation, and PKC{theta} is required for I{kappa}B{alpha} and I{kappa}B{epsilon} but not I{kappa}B{beta} degradation. PKC{theta} acts solely within the canonical pathway to activate NF-{kappa}B, and PKC{theta} deficiency impacts upon p100/p52 processing in a manner that is independent of NF-{kappa}B-induced kinase.


Received for publication, August 18, 2004 , and in revised form, November 4, 2004.

* This work was supported by National Institutes of Health Grants CA35299 and AI49888 (to A. A.) and AI51909 (to C. E. S.). This is publication 669 from the La Jolla Institute for Allergy and Immunology. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Both authors contributed equally to this work.

|| To whom correspondence should be addressed: Div. Of Cell Biology, La Jolla Inst. for Allergy and Immunology, 10355 Science Center Dr., San Diego, CA 92121. Tel.: 858-558-3527; Fax: 858-558-3526; E-mail: amnon{at}liai.org.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
J. Immunol.Home page
M. Sakowicz-Burkiewicz, G. Nishanth, U. Helmuth, K. Drogemuller, D. H. Busch, O. Utermohlen, M. Naumann, M. Deckert, and D. Schluter
Protein Kinase C-{theta} Critically Regulates the Proliferation and Survival of Pathogen-Specific T Cells in Murine Listeriosis
J. Immunol., April 15, 2008; 180(8): 5601 - 5612.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
D. Legarda-Addison and A. T. Ting
Negative Regulation of TCR Signaling by NF-{kappa}B2/p100
J. Immunol., June 15, 2007; 178(12): 7767 - 7778.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Heinemann, B. Biesinger, B. Fleckenstein, and J.-C. Albrecht
NF{kappa}B Signaling Is Induced by the Oncoprotein Tio through Direct Interaction with TRAF6
J. Biol. Chem., March 31, 2006; 281(13): 8565 - 8572.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2005 by the American Society for Biochemistry and Molecular Biology.